Myriad Genetics, Inc. (MYGN)
4.28
-0.34
(-7.36%)
USD |
NASDAQ |
Mar 27, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Shareholders Equity (Quarterly) : 368.00M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 52.13B |
| Insulet Corp. | 1.515B |
| Pacific Biosciences of California, Inc. | 5.349M |
| Tandem Diabetes Care, Inc. | 155.17M |
| iRhythm Holdings, Inc. | 152.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 706.60M |
| Total Liabilities (Quarterly) | 338.60M |
| Debt to Equity Ratio | 0.5701 |
| Current Ratio | 2.486 |
| Net Debt Paydown Yield | -2.32% |